Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Tianchen Peng"'
Autor:
Kangping Xiong, Gang Wang, Tianchen Peng, Fenfang Zhou, Siming Chen, Wei Liu, Lingao Ju, Yu Xiao, Kaiyu Qian, Xinghuan Wang
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background New effective drugs for prostate cancer (PCa) treatment are urgently needed. Avasimibe was recently identified as a promising drug for anticancer therapies. The main purpose of this study was to explore the effects and the underly
Externí odkaz:
https://doaj.org/article/57bf5138ea8844d188408764f8d0e484
Autor:
Songtao Cheng, Tianchen Peng, Xiaolu Zhu, Fenfang Zhou, Gang Wang, Lingao Ju, Yu Xiao, Xuefeng Liu, Xinghuan Wang
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Bladder cancer is having a gradually increasing incidence in China. Except for the traditional chemotherapy drugs, there are no emerging new drugs for almost 30 years in bladder cancer. New potential therapeutic targets and biomar
Externí odkaz:
https://doaj.org/article/f588adb34a9349dd90a4c2a44844eed3
Autor:
Siming Chen, Zhiwen He, Tianchen Peng, Fenfang Zhou, Gang Wang, Kaiyu Qian, Lingao Ju, Yu Xiao, Xinghuan Wang
Publikováno v:
JCI Insight, Vol 6, Iss 19 (2021)
Proline rich 11 (PRR11), a novel tumor-related gene, has been identified in different tumors. However, the relevant biological functions of PRR11 in human clear cell renal cell carcinoma (ccRCC) have not been studied. In this study, we first identifi
Externí odkaz:
https://doaj.org/article/6890ec4f4bd240a8a8727a98c3d6249b
Autor:
Liang Chen, Tianchen Peng, Yongwen Luo, Fenfang Zhou, Gang Wang, Kaiyu Qian, Yu Xiao, Xinghuan Wang
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Kidney cancer ranks as one of the top 10 causes of cancer death; this cancer is difficult to detect, difficult to treat, and poorly understood. The most common subtype of kidney cancer is clear cell renal cell carcinoma (ccRCC) and its progression is
Externí odkaz:
https://doaj.org/article/558aa90504c34431988a37dfde8f4e99
Autor:
Tianchen Peng1, Kangping Xiong1, Zhiwen He1, Songtao Cheng1, Siming Chen1, Song Chen1, Zhonghua Yang1, Wan Xiang2, Lingao Ju2,3,4, Yi Zhang5,6, Kaiyu Qian1,2, Yu Xiao2,4 yu.xiao@whu.edu.cn, Gang Wang1,2,3 gangwang.uro@whu.edu.cn
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 2, p370-382. 13p.
Autor:
Yu Xiao, Kangping Xiong, Gang Wang, Lingao Ju, Wei Liu, Kaiyu Qian, Xinghuan Wang, Tianchen Peng, Fenfang Zhou, Siming Chen
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-13 (2021)
Cancer Cell International
Cancer Cell International
Background New effective drugs for prostate cancer (PCa) treatment are urgently needed. Avasimibe was recently identified as a promising drug for anticancer therapies. The main purpose of this study was to explore the effects and the underlying mecha
Autor:
Lingao Ju, Yu Xiao, Yaoyi Xiong, Huimin Xu, Gang Wang, Tianchen Peng, Lushun Yuan, Xinghuan Wang, Yongwen Luo, Liang Chen
Publikováno v:
Oncogene. 40:1595-1608
KNSTRN is a component of the mitotic spindle, which was rarely investigated in tumorigenesis. AKT plays an essential role in tumorigenesis by modulating the phosphorylation of various substrates. The activation of AKT is regulated by PTEN and PIP3. H
Autor:
Gang Wang, Lingao Ju, Liang Chen, Tianchen Peng, Songtao Cheng, Xinghuan Wang, Rui Cao, Yaoyi Xiong, Kaiyu Qian, Yu Xiao, Lushun Yuan
Publikováno v:
OncoTargets and Therapy. 13:8825-8835
Introduction Based on accumulating evidence, transient receptor potential (TRP) ion channels may play important roles in the occurrence and the progression of cancer. TRP melastatin 8 (TRPM8), a member of the TRP family, functions as a Ca2+-permeable
Autor:
Xinghuan Wang, Songtao Cheng, Lingao Ju, Fenfang Zhou, Tianchen Peng, Yu Xiao, Xiaolu Zhu, Gang Wang, Xuefeng Liu
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-10 (2020)
Cancer Cell International
Cancer Cell International
Background Bladder cancer is having a gradually increasing incidence in China. Except for the traditional chemotherapy drugs, there are no emerging new drugs for almost 30 years in bladder cancer. New potential therapeutic targets and biomarkers are
Autor:
Tianchen Peng, Yu Xiao, Xinghuan Wang, Gang Wang, Yaoyi Xiong, Kaiyu Qian, Songtao Cheng, Rui Cao, Lingao Ju
Publikováno v:
Journal of Cancer
Peroxisome proliferator-activated receptor gamma (PPARγ), a member of the nuclear receptor superfamily, participates in multiple physiological and pathological processes. Extensive studies have revealed the relationship between PPARγ and various tu